Results 131 to 140 of about 15,396 (178)
Comparative cohort study of pregabalin nortriptyline and pregabalin duloxetine in the management of diabetic peripheral neuropathic pain. [PDF]
Dasari PC +8 more
europepmc +1 more source
Neuropsychiatric-pharmacologic synergy: interaction between psychiatric polypharmacy and cancer treatment-related neurotoxicity. [PDF]
Woytowitz SP, Manchee C.
europepmc +1 more source
A comparative evaluation of two clinical decision support systems for safer prescribing in older adults: an exploratory single-patient case study. [PDF]
Bobrova V +3 more
europepmc +1 more source
Neuropathic pain in diabetic patients: a review of pharmacological treatment selection according to psychopathological and somatic factors. [PDF]
Reginia A +6 more
europepmc +1 more source
Comparative Augmentative Efficacy of Second-Generation Antipsychotics in Adult Treatment-Resistant Depression: A Systematic Review. [PDF]
Khalid R +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Psychiatric Practice, 2004
Duloxetine is an orally administered, balanced, dual serotonin and norepinephrine (noradrenaline) reuptake inhibitor that increases neural input to the urethral sphincter, thereby relieving the symptoms of stress urinary incontinence (SUI). Duloxetine 40 mg twice daily for 12 weeks reduced the median incontinence episode frequency (IEF) to a ...
Paul L, McCormack, Gillian M, Keating
openaire +4 more sources
Duloxetine is an orally administered, balanced, dual serotonin and norepinephrine (noradrenaline) reuptake inhibitor that increases neural input to the urethral sphincter, thereby relieving the symptoms of stress urinary incontinence (SUI). Duloxetine 40 mg twice daily for 12 weeks reduced the median incontinence episode frequency (IEF) to a ...
Paul L, McCormack, Gillian M, Keating
openaire +4 more sources

